|
TANC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.401200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.690000E-02 |
| Normal-vs-Stage2 |
9.357200E-01 |
| Normal-vs-Stage3 |
7.960400E-01 |
| Normal-vs-Stage4 |
4.070400E-01 |
| Stage1-vs-Stage2 |
2.473200E-01 |
| Stage1-vs-Stage3 |
3.358400E-01 |
| Stage1-vs-Stage4 |
2.409600E-01 |
| Stage2-vs-Stage3 |
7.870800E-01 |
| Stage2-vs-Stage4 |
4.106000E-01 |
| Stage3-vs-Stage4 |
4.877400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.547210E-01 |
| Normal-vs-AfricanAmerican |
4.697600E-01 |
| Normal-vs-Asian |
8.946600E-01 |
| Caucasian-vs-AfricanAmerican |
7.060400E-01 |
| Caucasian-vs-Asian |
7.651800E-01 |
| AfricanAmerican-vs-Asian |
8.404000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.004300E-03 |
| Normal-vs-Female |
4.430100E-02 |
| Male-vs-Female |
2.600300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.978800E-01 |
| Normal-vs-Extreme_Weight |
2.388600E-04 |
| Normal-vs-Obese |
8.942400E-01 |
| Normal-vs-Extreme_Obese |
4.481700E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.620400E-02 |
| Normal_Weight-vs-Obese |
6.637400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.555600E-02 |
| Extreme_Weight-vs-Obese |
2.306100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.294200E-01 |
| Obese-vs-Extreme_Obese |
3.093700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.055000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.957800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.815520E-02 |
| Normal-vs-Age(81-100Yrs) |
1.85863999999647E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.712810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.016400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.282200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.020100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.38900000001829E-06 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.376100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.395600E-02 |
| Normal-VS-Type2 PRCC |
3.399700E-02 |
| Normal-VS-KIRP CIMP |
4.499900E-02 |
| Normal-VS-Unclassified PRCC |
5.875800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.162000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.708400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.687800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.640400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.812400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.935900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.357800E-03 |
| Normal-vs-N1 |
3.101800E-01 |
| Normal-vs-N2 |
5.050800E-01 |
| N0-vs-N1 |
6.899900E-02 |
| N0-vs-N2 |
3.901800E-01 |
| N1-vs-N2 |
5.557400E-01 |
|
|
